Merck & Co is preparing the launch of Gardasil, the first human papillomavirus (HPV) vaccine. Because knowledge of HPV is poor among potential vaccinees and other stakeholders (parents, physicians, third-party payers), and there is no habit of vaccinating adolescents, Merck needs to develop pre-launch programmes. Which  potential vaccinees to target and how to position Gardasil -
to  prevent HPV, genital warts, cervical cancer, or both genital warts and cervical cancer - are other important decisions.
-  Market creation
-  Marketing a prevention product
-  Pre-launch and launch marketing
-  Segmentation and positioning
-  Developing a marketing programmefor multiple stakeholders
- Marketing
 - Pharmaceutical
 - New product
 - Positioning
 - Prevention
 - Vaccination
 - Disease awareness
 - Market creation
 - Q21415